Shaoqiu Wu

637 citations
16 papers · 500 indexed · h-index 11
Topics
MicroRNA in disease regulation (8 papers)Cancer-related molecular mechanisms research (7 papers)RNA modifications and cancer (4 papers)
Partner nations
China

In The Last Decade

Shaoqiu Wu

15 papers receiving 498 citations

Peers

Shaoqiu Wu
Comparison fields: 5 of 62
  • Molecular Biology 355
  • Cancer Research 311
  • Oncology 101
  • Immunology 71
  • Pulmonary and Respiratory Medicine 48
Replace Mengqin Shen with:
Mengqin Shen China
Qingke Duan China
Xiaolu Cui China
Jing Cui China
Susanne van Schelven Netherlands
Qian Gou China
Tienian Zhu China
Shi-Rong Zhang China
Xuan Yi China
Shaoqiu Wu relative to Mengqin Shen China Mengqin Shen's profile →
Citations per field
00.5×
Mengqin Shen · 1×
Citations per year

Countries citing papers authored by Shaoqiu Wu

Since Specialization
Citations

This map shows the geographic impact of Shaoqiu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoqiu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoqiu Wu more than expected).

Fields of papers citing papers by Shaoqiu Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoqiu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoqiu Wu. The network helps show where Shaoqiu Wu may publish in the future.

Co-authorship network of co-authors of Shaoqiu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoqiu Wu. A scholar is included among the top collaborators of Shaoqiu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoqiu Wu. Shaoqiu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 0
2 8
3 6
4 11
5
HP1BP3 promotes tumor growth and metastasis by upregulating miR-23a to target TRAF5 in esophageal squamous cell carcinoma.
7
6 31
7 38
8 7
9 139
10 36
11
MiR-4262 promotes cell apoptosis and inhibits proliferation of colon cancer cells: involvement of GALNT4.
23
12 15
13 62
14 49
15 21
16 47

About Shaoqiu Wu

Shaoqiu Wu is a scholar working on Cancer Research, Toxicology and Speech and Hearing, having authored 16 papers that have together received 500 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (7 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (311 citations), Molecular Biology (355 citations) and Oncology (101 citations). Shaoqiu Wu has collaborated with scholars based in China. Frequent co-authors include Aiwu Mao, Mingyi Shang, Bingyan Liu, Yiping Jia, Shuo Yan, Xiang Yin, Jun Ma, Xianjun Sun, Bingyan Liu and Feng Zhang. Their work appears in journals such as Archives of Biochemistry and Biophysics, Experimental Cell Research and Journal of Cellular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026